1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Stage I Invasive Breast Cancer 1.2.3 Stage II Invasive Breast Cancer 1.2.4 Estrogen Receptor-positive Cancer 1.2.5 Lymph Node-negative Breast Cancer 1.3 Market by Application 1.3.1 Global Breast Cancer Recurrence Score Test Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Speciality Cancer Centers 1.3.4 Advanced Diagnostic Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Breast Cancer Recurrence Score Test Market Perspective (2018-2029) 2.2 Breast Cancer Recurrence Score Test Growth Trends by Region 2.2.1 Global Breast Cancer Recurrence Score Test Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Breast Cancer Recurrence Score Test Historic Market Size by Region (2018-2023) 2.2.3 Breast Cancer Recurrence Score Test Forecasted Market Size by Region (2024-2029) 2.3 Breast Cancer Recurrence Score Test Market Dynamics 2.3.1 Breast Cancer Recurrence Score Test Industry Trends 2.3.2 Breast Cancer Recurrence Score Test Market Drivers 2.3.3 Breast Cancer Recurrence Score Test Market Challenges 2.3.4 Breast Cancer Recurrence Score Test Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue 3.1.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue (2018-2023) 3.1.2 Global Breast Cancer Recurrence Score Test Revenue Market Share by Players (2018-2023) 3.2 Global Breast Cancer Recurrence Score Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Breast Cancer Recurrence Score Test Revenue 3.4 Global Breast Cancer Recurrence Score Test Market Concentration Ratio 3.4.1 Global Breast Cancer Recurrence Score Test Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Recurrence Score Test Revenue in 2022 3.5 Breast Cancer Recurrence Score Test Key Players Head office and Area Served 3.6 Key Players Breast Cancer Recurrence Score Test Product Solution and Service 3.7 Date of Enter into Breast Cancer Recurrence Score Test Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Breast Cancer Recurrence Score Test Breakdown Data by Type 4.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Type (2018-2023) 4.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2024-2029) 5 Breast Cancer Recurrence Score Test Breakdown Data by Application 5.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Application (2018-2023) 5.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Breast Cancer Recurrence Score Test Market Size (2018-2029) 6.2 North America Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) 6.4 North America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Breast Cancer Recurrence Score Test Market Size (2018-2029) 7.2 Europe Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) 7.4 Europe Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Breast Cancer Recurrence Score Test Market Size (2018-2029) 8.2 Asia-Pacific Breast Cancer Recurrence Score Test Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2018-2023) 8.4 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Breast Cancer Recurrence Score Test Market Size (2018-2029) 9.2 Latin America Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) 9.4 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Breast Cancer Recurrence Score Test Market Size (2018-2029) 10.2 Middle East & Africa Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) 10.4 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Roche Diagnostics 11.1.1 Roche Diagnostics Company Detail 11.1.2 Roche Diagnostics Business Overview 11.1.3 Roche Diagnostics Breast Cancer Recurrence Score Test Introduction 11.1.4 Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.1.5 Roche Diagnostics Recent Development 11.2 Braster 11.2.1 Braster Company Detail 11.2.2 Braster Business Overview 11.2.3 Braster Breast Cancer Recurrence Score Test Introduction 11.2.4 Braster Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.2.5 Braster Recent Development 11.3 Bremed 11.3.1 Bremed Company Detail 11.3.2 Bremed Business Overview 11.3.3 Bremed Breast Cancer Recurrence Score Test Introduction 11.3.4 Bremed Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.3.5 Bremed Recent Development 11.4 Forward Science Technologies 11.4.1 Forward Science Technologies Company Detail 11.4.2 Forward Science Technologies Business Overview 11.4.3 Forward Science Technologies Breast Cancer Recurrence Score Test Introduction 11.4.4 Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.4.5 Forward Science Technologies Recent Development 11.5 Guided Therapeutics 11.5.1 Guided Therapeutics Company Detail 11.5.2 Guided Therapeutics Business Overview 11.5.3 Guided Therapeutics Breast Cancer Recurrence Score Test Introduction 11.5.4 Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.5.5 Guided Therapeutics Recent Development 11.6 Varian Medical Systems 11.6.1 Varian Medical Systems Company Detail 11.6.2 Varian Medical Systems Business Overview 11.6.3 Varian Medical Systems Breast Cancer Recurrence Score Test Introduction 11.6.4 Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.6.5 Varian Medical Systems Recent Development 11.7 LED Dental 11.7.1 LED Dental Company Detail 11.7.2 LED Dental Business Overview 11.7.3 LED Dental Breast Cancer Recurrence Score Test Introduction 11.7.4 LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.7.5 LED Dental Recent Development 11.8 PWB Health 11.8.1 PWB Health Company Detail 11.8.2 PWB Health Business Overview 11.8.3 PWB Health Breast Cancer Recurrence Score Test Introduction 11.8.4 PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.8.5 PWB Health Recent Development 11.9 Zilico Medical Diagnostics 11.9.1 Zilico Medical Diagnostics Company Detail 11.9.2 Zilico Medical Diagnostics Business Overview 11.9.3 Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Introduction 11.9.4 Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) 11.9.5 Zilico Medical Diagnostics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Stage I Invasive Breast Cancer Table 3. Key Players of Stage II Invasive Breast Cancer Table 4. Key Players of Estrogen Receptor-positive Cancer Table 5. Key Players of Lymph Node-negative Breast Cancer Table 6. Global Breast Cancer Recurrence Score Test Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Breast Cancer Recurrence Score Test Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Breast Cancer Recurrence Score Test Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Breast Cancer Recurrence Score Test Market Share by Region (2018-2023) Table 10. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Breast Cancer Recurrence Score Test Market Share by Region (2024-2029) Table 12. Breast Cancer Recurrence Score Test Market Trends Table 13. Breast Cancer Recurrence Score Test Market Drivers Table 14. Breast Cancer Recurrence Score Test Market Challenges Table 15. Breast Cancer Recurrence Score Test Market Restraints Table 16. Global Breast Cancer Recurrence Score Test Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Breast Cancer Recurrence Score Test Market Share by Players (2018-2023) Table 18. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Recurrence Score Test as of 2022) Table 19. Ranking of Global Top Breast Cancer Recurrence Score Test Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Breast Cancer Recurrence Score Test Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Breast Cancer Recurrence Score Test Product Solution and Service Table 23. Date of Enter into Breast Cancer Recurrence Score Test Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Breast Cancer Recurrence Score Test Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2018-2023) Table 27. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2024-2029) Table 29. Global Breast Cancer Recurrence Score Test Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2018-2023) Table 31. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2024-2029) Table 33. North America Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Breast Cancer Recurrence Score Test Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million) Table 48. Roche Diagnostics Company Detail Table 49. Roche Diagnostics Business Overview Table 50. Roche Diagnostics Breast Cancer Recurrence Score Test Product Table 51. Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 52. Roche Diagnostics Recent Development Table 53. Braster Company Detail Table 54. Braster Business Overview Table 55. Braster Breast Cancer Recurrence Score Test Product Table 56. Braster Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 57. Braster Recent Development Table 58. Bremed Company Detail Table 59. Bremed Business Overview Table 60. Bremed Breast Cancer Recurrence Score Test Product Table 61. Bremed Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 62. Bremed Recent Development Table 63. Forward Science Technologies Company Detail Table 64. Forward Science Technologies Business Overview Table 65. Forward Science Technologies Breast Cancer Recurrence Score Test Product Table 66. Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 67. Forward Science Technologies Recent Development Table 68. Guided Therapeutics Company Detail Table 69. Guided Therapeutics Business Overview Table 70. Guided Therapeutics Breast Cancer Recurrence Score Test Product Table 71. Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 72. Guided Therapeutics Recent Development Table 73. Varian Medical Systems Company Detail Table 74. Varian Medical Systems Business Overview Table 75. Varian Medical Systems Breast Cancer Recurrence Score Test Product Table 76. Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 77. Varian Medical Systems Recent Development Table 78. LED Dental Company Detail Table 79. LED Dental Business Overview Table 80. LED Dental Breast Cancer Recurrence Score Test Product Table 81. LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 82. LED Dental Recent Development Table 83. PWB Health Company Detail Table 84. PWB Health Business Overview Table 85. PWB Health Breast Cancer Recurrence Score Test Product Table 86. PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 87. PWB Health Recent Development Table 88. Zilico Medical Diagnostics Company Detail Table 89. Zilico Medical Diagnostics Business Overview Table 90. Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Product Table 91. Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million) Table 92. Zilico Medical Diagnostics Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Breast Cancer Recurrence Score Test Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Breast Cancer Recurrence Score Test Market Share by Type: 2022 VS 2029 Figure 3. Stage I Invasive Breast Cancer Features Figure 4. Stage II Invasive Breast Cancer Features Figure 5. Estrogen Receptor-positive Cancer Features Figure 6. Lymph Node-negative Breast Cancer Features Figure 7. Global Breast Cancer Recurrence Score Test Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Breast Cancer Recurrence Score Test Market Share by Application: 2022 VS 2029 Figure 9. Hospitals Case Studies Figure 10. Speciality Cancer Centers Case Studies Figure 11. Advanced Diagnostic Centers Case Studies Figure 12. Others Case Studies Figure 13. Breast Cancer Recurrence Score Test Report Years Considered Figure 14. Global Breast Cancer Recurrence Score Test Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 15. Global Breast Cancer Recurrence Score Test Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 16. Global Breast Cancer Recurrence Score Test Market Share by Region: 2022 VS 2029 Figure 17. Global Breast Cancer Recurrence Score Test Market Share by Players in 2022 Figure 18. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Recurrence Score Test as of 2022) Figure 19. The Top 10 and 5 Players Market Share by Breast Cancer Recurrence Score Test Revenue in 2022 Figure 20. North America Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. North America Breast Cancer Recurrence Score Test Market Share by Country (2018-2029) Figure 22. United States Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Canada Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Breast Cancer Recurrence Score Test Market Share by Country (2018-2029) Figure 26. Germany Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. France Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. U.K. Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Italy Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Russia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Nordic Countries Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Breast Cancer Recurrence Score Test Market Share by Region (2018-2029) Figure 34. China Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Japan Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. South Korea Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Southeast Asia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. India Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Australia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Breast Cancer Recurrence Score Test Market Share by Country (2018-2029) Figure 42. Mexico Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Brazil Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Breast Cancer Recurrence Score Test Market Share by Country (2018-2029) Figure 46. Turkey Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Saudi Arabia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Roche Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 49. Braster Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 50. Bremed Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 51. Forward Science Technologies Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 52. Guided Therapeutics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 53. Varian Medical Systems Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 54. LED Dental Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 55. PWB Health Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 56. Zilico Medical Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Roche Diagnostics Braster Bremed Forward Science Technologies Guided Therapeutics Varian Medical Systems LED Dental PWB Health Zilico Medical Diagnostics